A Phase I Study of Veliparib (ABT-888) in Combination with Low-Dose Fractionated Whole Abdominal Radiation Therapy in Patients with Advanced Solid Malignancies and Peritoneal CarcinomatosisKim A. Reiss, Nilofer S. Azad, Laura A. Dawson et al.|Clinical Cancer Research|2014Cited by 75
A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancersKim A. Reiss, Nilofer S. Azad, Joseph M. Herman et al.|Gynecologic Oncology|2017Cited by 53